Academic health system bolsters payer strategy, adds $450M in revenue

Challenge 

A Northeast health system faced growing reimbursement and margin pressure across commercial, Medicare, Medicaid, Managed Medicaid, and Medicare Advantage lines of business. As one of the nation's largest academic health systems with revenues of more than $10 billion, the organization faced growing pressure to sustain financial performance amid rising labor costs, inflationary expense growth, increasing clinical complexity, and a persistent decline in public payer reimbursement. Commercial reimbursement had become the primary source of margin support for the enterprise, yet many payer relationships and reimbursement arrangements failed to accurately reflect the value of the organization and the breadth and sophistication of its services. 

Leadership recognized that traditional contract-by-contract negotiation tactics were no longer sufficient. The organization needed a more sophisticated payer strategy capable of addressing significant variation in reimbursement across payers, service lines, hospitals, and physician practices and aligning payment with the complexity and acuity of care delivered across the system.

At the same time, several large commercial payer contracts representing billions of dollars in annual revenue were approaching critical renewal periods. Increasing pressure from health plans, employer coalitions, reference-based pricing programs, and value-based reimbursement models were creating uncertainty around future revenue performance and negotiating leverage.

The health system needed a strategic partner capable of helping the organization move beyond individual contract negotiations and toward an enterprisewide payer portfolio strategy. Leadership sought to establish a data-driven foundation for reimbursement decision-making, strengthen negotiating readiness, improve contract yield performance, diversify commercial growth opportunities, and position the health system for sustainable long-term financial success.

Approach

Guidehouse brought together a multi-disciplinary team of finance, revenue cycle, and managed care experts to create an overarching enterprise payer strategy. Unlike traditional managed care advisory engagements that focus primarily on contract negotiations, the project was designed to optimize the health system's entire payer portfolio, improve revenue realization, and strengthen long-term enterprise value.

Through a multi-year engagement, we drove results across the health system’s entire portfolio. Early on, that meant improving rates and increasing revenue among major commercial payers. Today, as the relationship continues, we’ve focused on articulating a defensive strategy for the organization that helps leaders weather regulatory changes and optimize revenue across each line of its business. 

The work has been structured into six connected workstreams: 

Commercial benchmarking and price transparency foundation: Our teams have established hospital- and professional-based commercial reimbursement benchmarks, refreshed an analysis of the health system’s market position, and used external transparency data to create defensible, evidence-based negotiation strategies.

Revenue rebalancing and payer portfolio economics: Our experts have helped rebalance revenue strategies at both the payer and service line levels. Revenue rebalancing is the process of strategically reshaping a health system's reimbursement portfolio so that rates, volumes, and margins are better aligned with the value of care delivered, market conditions, and long-term growth objectives. 

Contract negotiation strategy and financial modeling: We support payer negotiations that represent more than $5 billion in annual health system revenue through scenario modeling, counterproposal strategy, contract reviews, termination and out-of-network risk analysis, and leadership-ready decision support for major commercial payer relationships. 

Managed care strategy and yield discipline: We’ve helped the health system turn payer contract gains into measurable financial performance by improving contract yield, strengthening operational accountability, and creating better alignment across managed care and revenue cycle functions. The result is a more disciplined approach to capturing revenue, reducing leakage, and monitoring payer performance.

Commercial growth and purchaser diversification: The health system needed to diversify its commercial payer strategy beyond major health plans. We’ve helped leaders articulate their response to reference pricing, created bundled pricing options, and designed a framework for direct-to-employer and centers of excellence arrangements. 

Specialty payer and complex care economics: We’ve developed advanced strategies for transplant, behavioral health, auto injury, workers’ compensation, and other specialty payer areas where defined rules, clinical differentiation, and operational discipline can strengthen revenue capture and market positioning.

Impact

Working together with Guidehouse, the health system has established a more sophisticated, data-driven approach to managing its payer portfolio. This positions the organization to strengthen its financial performance, improve reimbursement defensibility, and support long-term growth.

Key outcomes include:

Significant financial impact: Recommended strategy and reimbursement improvements have generated an estimated $450 million in additional net revenue opportunity, including approximately $85 million in additional annual net revenue from priority commercial payer relationships and a projected 20% reduction in public payer losses. We’ve also helped the health system recoup $40 million in underpayments from a major payer.

A defensible payer strategy foundation: Leadership has gained a comprehensive view of commercial market position, facility and professional reimbursement performance, service line economics, and contract yield dynamics, enabling more informed payer decision-making across the enterprise.

Improved reimbursement and contract positioning: The health system has strengthened its ability to support reimbursement improvements through objective benchmarking and payer-specific economic analysis. This helps align payment with the complexity, acuity, and value of care delivered.

Enhanced negotiation readiness and decision support: Executive leadership has gained the tools, analytics, and scenario modeling capabilities needed to evaluate complex tradeoffs across reimbursement methodologies, network participation, contractual language, risk-sharing arrangements, and operational commitments. With our assistance, the health system has also resolved two large health plan contract terminations totaling $1.8 billion in revenue.

Transformation of managed care into a strategic enterprise function: Managed care has evolved from a transactional contracting activity into a core component of the health system's financial and growth strategy, supported by stronger governance, analytics, and performance management disciplines.

Expansion of commercial growth opportunities: A more diversified payer and purchaser strategy has positioned the health system to pursue new growth channels, including employer-focused arrangements, innovative reimbursement models, and other strategic partnerships.